{"id":"acetic-acid-glacial","rwe":[],"tags":[],"phase":"marketed","safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":["Fungal ear infection","Herpes simplex","Herpes zoster auricularis","Infective otitis media","Perforation of tympanic membrane","Porphyria","Sensation Disturbance of Genitals","Tuberculosis of ear","Viral ear infection"],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"status":"approved","trials":["NCT00250055","NCT00373100","NCT03596099","NCT02309424","NCT02363244","NCT02620956","NCT06437405","NCT00760396","NCT04878003","NCT00268697","NCT05604248","NCT05073211","NCT02338141","NCT02157506","NCT01466959","NCT03369002","NCT04794660","NCT04189874","NCT02873741","NCT00977600","NCT02848937","NCT05022524","NCT04024813","NCT06457373","NCT01633541","NCT05008250","NCT00256178","NCT01299701","NCT02002208","NCT05802121","NCT05503368","NCT07240220","NCT05698381","NCT02335372","NCT01031212","NCT02733185","NCT01096004","NCT05476952","NCT03111810","NCT00286780","NCT02689024","NCT06748313","NCT02472535","NCT01285635","NCT06411938","NCT01568216","NCT04502394","NCT00569972","NCT00571675","NCT00813527"],"aliases":[],"company":"CHARTWELL RX","patents":[],"pricing":[],"allNames":"acetic acid","offLabel":[],"timeline":[],"brandName":"ACETIC ACID","ecosystem":[],"mechanism":{"target":"Free fatty acid receptor 3, Tyrosine-protein kinase Fyn, Tyrosine-protein kinase Lck","novelty":"","modality":"Small Molecule","drugClass":"","explanation":"","oneSentence":""},"commercial":null,"references":[],"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://www.fda.gov/drugs","name":"FDA Drugs@FDA","fields":["phase","status","brandName","company"],"retrievedDate":"2026-04-07"},{"url":"https://clinicaltrials.gov","name":"ClinicalTrials.gov","fields":["trialDetails","trials"],"retrievedDate":"2026-04-07"},{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"genericName":"ACETIC ACID, GLACIAL","indications":{"approved":[{"name":"Otitis externa","diseaseId":"otitis-externa","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"currentOwner":"CHARTWELL RX","labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT00250055","phase":"NA","title":"Non-Invasive, Real-time Technology for Diagnosis of Cervical Tissue","status":"TERMINATED","sponsor":"University of New Mexico","isPivotal":false,"enrollment":100,"indication":"Cervix, Cancer","completionDate":"2010-01"},{"nctId":"NCT00373100","phase":"Phase 3","title":"The Efficacy of Zinc as Adjunct Therapy in the Treatment of Severe Pneumonia in Children Admitted to Mulago Hospital, Uganda.","status":"COMPLETED","sponsor":"Makerere University","isPivotal":true,"enrollment":328,"indication":"Pneumonia","completionDate":"2007-03"},{"nctId":"NCT03596099","phase":"NA","title":"Rice Vinegar as an Intervention to Lower Blood Pressure in Adults With Prehypertension and 10-year CVD Risk <10%","status":"UNKNOWN","sponsor":"Mizkan Holdings Co., Ltd.","isPivotal":false,"enrollment":130,"indication":"Prehypertension","completionDate":"2019-10-01"},{"nctId":"NCT02309424","phase":"NA","title":"The Effect of Vinegar on Glucose and Lipid Metabolism in Peripheral Tissues in Subjects With Impaired Glucose Tolerance or Type 2 Diabetes","status":"COMPLETED","sponsor":"Attikon Hospital","isPivotal":false,"enrollment":20,"indication":"Type 2 Diabetes","completionDate":"2014-12"},{"nctId":"NCT02363244","phase":"N/A","title":"A Pilot Study on Comparative Evaluation of Results of Pap Smears and HPV Hybrid Capture 2 Performed on Cervical Samples Before and After Application of Acetic Acid","status":"COMPLETED","sponsor":"Tata Memorial Hospital","isPivotal":false,"enrollment":50,"indication":"CIN","completionDate":"2015-12"},{"nctId":"NCT02620956","phase":"Phase 2","title":"Aerosol Deposition in Asthmatic Obese Women Using Heliox: A Randomized, Crossover, Controlled Clinical Trial Study","status":"COMPLETED","sponsor":"Jacqueline de Melo Barcelar","isPivotal":false,"enrollment":20,"indication":"Obese, Asthma","completionDate":"2016-01"},{"nctId":"NCT06437405","phase":"NA","title":"The Effects of a 12-Week Resistance Exercise Program Plus Vinegar Ingestion on Biomarkers of Intestinal Permeability, Cognition, and Mood State in Healthy Adults","status":"COMPLETED","sponsor":"Arizona State University","isPivotal":false,"enrollment":29,"indication":"LPS, Mood Disorders","completionDate":"2025-02-15"},{"nctId":"NCT00760396","phase":"Phase 1","title":"A Placebo-Controlled, Ascending Multiple-Dose Study to Evaluate the Safety and Pharmacokinetics of VGX-1027 in Healthy Subjects","status":"COMPLETED","sponsor":"VGX Pharmaceuticals, LLC","isPivotal":false,"enrollment":40,"indication":"Healthy","completionDate":"2009-04"},{"nctId":"NCT04878003","phase":"Phase 2","title":"An Open-Label, Multicenter, Phase 2 Study Assessing the Safety and Efficacy of KRT-232 or TL-895 in Janus Associated Kinase Inhibitor Treatment-Naïve Myelofibrosis","status":"UNKNOWN","sponsor":"Kartos Therapeutics, Inc.","isPivotal":false,"enrollment":52,"indication":"Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV-MF)","completionDate":"2025-10"},{"nctId":"NCT00268697","phase":"Phase 3","title":"A Double-Blind, Double-Dummy, Randomized, Parallel Group, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of Lapaquistat Acetate 100 mg and Lapaquistat Acetate 100 mg Administered in Co","status":"COMPLETED","sponsor":"Takeda","isPivotal":true,"enrollment":1267,"indication":"Hypercholesterolemia","completionDate":"2007-01"},{"nctId":"NCT05604248","phase":"NA","title":"Kinetics of Retinol and Total Body Stores Among Lactating Senegalese Women Living in an Urban Setting and the Relationship Between Their Total Body Stores and Those of Their Infants","status":"UNKNOWN","sponsor":"Cheikh Anta Diop University, Senegal","isPivotal":false,"enrollment":56,"indication":"Vitamin A","completionDate":"2023-07-08"},{"nctId":"NCT05073211","phase":"NA","title":"A Randomized Split-face Study of Photodynamic Therapy With St. John's Wort Versus Indole-3-acetic Acid for the Treatment of Acne","status":"COMPLETED","sponsor":"Seoul National University Bundang Hospital","isPivotal":false,"enrollment":31,"indication":"Acne","completionDate":"2021-09-01"},{"nctId":"NCT02338141","phase":"NA","title":"Evaluating the Accuracy of Portable Colposcopy and Prevalent HPV Genotypes Among HIV Positive Women in Haiti","status":"TERMINATED","sponsor":"Duke University","isPivotal":false,"enrollment":132,"indication":"Cervical Cancer, Human Papillomavirus","completionDate":"2016-02"},{"nctId":"NCT02157506","phase":"Phase 2","title":"A Phase IIa Study of the Safety, Tolerability and Hemodynamic Effects of a Continuous 6 Hour Intravenous Infusion of CXL-1427 in Hospitalized Patients With Systolic Heart Failure","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","isPivotal":false,"enrollment":70,"indication":"Heart Failure, Decompensated Heart Failure","completionDate":"2015-07-31"},{"nctId":"NCT01466959","phase":"NA","title":"The Effect of Citrasate Dialysate on Heparin Dose: A Randomized Cross Over Trial in Hemodialysis Patients.","status":"COMPLETED","sponsor":"University of Calgary","isPivotal":false,"enrollment":20,"indication":"Chronic Kidney Disease","completionDate":"2013-01"},{"nctId":"NCT03369002","phase":"Phase 1","title":"A Phase 1, Open Label, Non-Randomized Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Oral Seladelpar in Subjects With Varying Degrees of Hepatic Impairment and Healthy Matched Con","status":"COMPLETED","sponsor":"Gilead Sciences","isPivotal":false,"enrollment":32,"indication":"Hepatic Impairment","completionDate":"2018-05-15"},{"nctId":"NCT04794660","phase":"Phase 3","title":"The Study for the \"Cervical Cancer Screening and Treatment Algorithms Study Using HPV Testing in Africa\"","status":"UNKNOWN","sponsor":"International Agency for Research on Cancer","isPivotal":true,"enrollment":1500,"indication":"HPV Infection","completionDate":"2025-10-01"},{"nctId":"NCT04189874","phase":"NA","title":"Efficacy of BioFire FilmArray Gastrointestinal Panel (FGP) to Reduce Hospital Costs Associated With Contact Isolation","status":"COMPLETED","sponsor":"Giulio DiDiodato","isPivotal":false,"enrollment":156,"indication":"Infectious Gastroenteritis","completionDate":"2021-02-12"},{"nctId":"NCT02873741","phase":"N/A","title":"New Strategies to Assess Anal Cancer Risk In Women","status":"COMPLETED","sponsor":"Emory University","isPivotal":false,"enrollment":143,"indication":"Human Immunodeficiency Virus (HIV), Human Papillomavirus (HPV)","completionDate":"2017-02-27"},{"nctId":"NCT00977600","phase":"Phase 1","title":"A Randomized, Crossover, Open-label Phase 1 Study of Glyceryl Tri-(4-phenylbutyrate) (GT4P)","status":"COMPLETED","sponsor":"Amgen","isPivotal":false,"enrollment":24,"indication":"Healthy","completionDate":"2005-07"},{"nctId":"NCT02848937","phase":"N/A","title":"Calcium Mass Balance and Dialytic Efficiency of a New cITRate-containing and Acetate-free Dialysis flUidS: CITRUS Study","status":"UNKNOWN","sponsor":"Azienda Ospedaliera, Ospedale Civile di Legnano","isPivotal":false,"enrollment":62,"indication":"ESRD","completionDate":"2016-12"},{"nctId":"NCT05022524","phase":"Phase 1","title":"Exploring Novel Uses of Microbiota Therapy for Managing the Side Effects of Psychiatric Pharmaceutical Interventions: An N-of-1 Pilot and Feasibility Study","status":"UNKNOWN","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","isPivotal":false,"enrollment":10,"indication":"Depression, Anxiety","completionDate":"2024-08-31"},{"nctId":"NCT04024813","phase":"Phase 2","title":"A Phase 2, Randomized, Double Blind, Placebo Controlled, Multiple Center Study to Evaluate the Safety, Tolerability, and Efficacy of Seladelpar Administered for 24 Weeks in Adult Patients With Primary","status":"TERMINATED","sponsor":"Gilead Sciences","isPivotal":false,"enrollment":1,"indication":"Primary Sclerosing Cholangitis","completionDate":"2020-01-09"},{"nctId":"NCT06457373","phase":"NA","title":"The Demineralized Dentin Allograft Versus Demineralized Dentin Autograft for Socket Preservation After Surgical Extraction of Impacted Mandibular Third Molar","status":"NOT_YET_RECRUITING","sponsor":"Horus University","isPivotal":false,"enrollment":40,"indication":"Alveolar Bone Loss","completionDate":"2027-07-30"},{"nctId":"NCT01633541","phase":"Phase 2","title":"Concomitant Chemotherapy AND Bcl-xL Inhibitor (AT-101) For Bio-selection For Organ Preservation In Patients With Advanced Laryngeal Cancer","status":"COMPLETED","sponsor":"University of Michigan Rogel Cancer Center","isPivotal":false,"enrollment":55,"indication":"Laryngeal Cancer","completionDate":"2021-11-06"},{"nctId":"NCT05008250","phase":"Phase 4","title":"Efficacy and Safety of Metoprolol Tartrate Tablets Combined With Chinese Traditional Medicine on Premature Ventricular Complex: a Multicenter, Randomized, Double-blind, Parallel Controlled Clinical St","status":"COMPLETED","sponsor":"Xuanwu Hospital, Beijing","isPivotal":false,"enrollment":584,"indication":"Premature Ventricular Contraction","completionDate":"2016-08"},{"nctId":"NCT00256178","phase":"Phase 3","title":"A Placebo-controlled, Double-blind, Randomized Study to Evaluate the Efficacy and Safety of TAK-475 50 mg and 100 mg Versus Placebo, When Co-administered With Simvastatin 20 mg or 40 mg in Subjects Wi","status":"COMPLETED","sponsor":"Takeda","isPivotal":true,"enrollment":411,"indication":"Hypercholesterolemia","completionDate":"2007-03"},{"nctId":"NCT01299701","phase":"Phase 1","title":"An Open-label Single Center Study to Characterize the Absorption, Distribution, Metabolism, and Excretion (ADME) of ASA404 After a Single Intravenous Infusion of 3000 mg [14C]ASA404 in Patients With A","status":"TERMINATED","sponsor":"Novartis Pharmaceuticals","isPivotal":false,"enrollment":7,"indication":"Advanced Solid Tumors","completionDate":"2009-07"},{"nctId":"NCT02002208","phase":"Phase 2","title":"A Study of the Effect of OC000459 on Signs and Symptoms in Subjects With Moderate to Severe Atopic Dermatitis: A Randomised Double Blind Placebo Controlled Parallel Group Study","status":"COMPLETED","sponsor":"Atopix Therapeutics, Ltd.","isPivotal":false,"enrollment":142,"indication":"Atopic Dermatitis","completionDate":"2016-02"},{"nctId":"NCT05802121","phase":"EARLY/Phase 1","title":"The Role of Akkermansia Muciniphilia in Combating the Metabolic Effects of Androgen Deprivation Therapy in Men With Metastatic Prostate Cancer","status":"RECRUITING","sponsor":"Western University","isPivotal":false,"enrollment":30,"indication":"Prostate Cancer, Metabolic Syndrome","completionDate":"2027-06"},{"nctId":"NCT05503368","phase":"NA","title":"Autologous Cellular Micro-graft in Surgical Treatment of Stable Resistant Vitiligo: A Randomized Self-controlled Trial","status":"SUSPENDED","sponsor":"Cairo University","isPivotal":false,"enrollment":20,"indication":"Vitiligo, Generalized","completionDate":"2024-04"},{"nctId":"NCT07240220","phase":"NA","title":"The Mother-Daughter Project: Inclusion of Difficult-to-reach Kenyan Families, and Studies of Factors Influencing the Immune Response to HPV Vaccination (Merck-4)","status":"NOT_YET_RECRUITING","sponsor":"Indiana University","isPivotal":false,"enrollment":2500,"indication":"Cervical Dysplasia","completionDate":"2028-08-01"},{"nctId":"NCT05698381","phase":"NA","title":"Effect of Daily Vinegar Ingestion for Four Weeks on Mood State, Inflammatory State, and Risk for Metabolic Syndrome in Healthy Adults","status":"COMPLETED","sponsor":"Arizona State University","isPivotal":false,"enrollment":36,"indication":"Inflammation, Metabolic Syndrome","completionDate":"2023-08-15"},{"nctId":"NCT02335372","phase":"NA","title":"A Pilot Study of a Low-Cost Optical Imaging Tool for Cervical Cancer Screening in Brazil","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","isPivotal":false,"enrollment":300,"indication":"Cervical Cancer","completionDate":"2021-10-07"},{"nctId":"NCT01031212","phase":"Phase 1","title":"A Phase I Study of ASA 404 in Combination With Carboplatin/Paclitaxel/Cetuximab in Patients With Refractory Solid Tumors","status":"WITHDRAWN","sponsor":"University of California, San Francisco","isPivotal":false,"enrollment":0,"indication":"Tumors","completionDate":"2013-06"},{"nctId":"NCT02733185","phase":"Phase 3","title":"Trial to Assess Chelation Therapy 2","status":"COMPLETED","sponsor":"Mt. Sinai Medical Center, Miami","isPivotal":true,"enrollment":1000,"indication":"Diabetes, Myocardial Infarction","completionDate":"2023-06-30"},{"nctId":"NCT01096004","phase":"Phase 1","title":"A Randomised, Single-blind, Placebo-controlled, Single-centre, Phase I Study in Abdominally Obese Healthy Volunteers to Evaluate Methods to Assess 11-βHSD1 Activity in Adipose Tissue and Related Downs","status":"COMPLETED","sponsor":"AstraZeneca","isPivotal":false,"enrollment":15,"indication":"Obesity","completionDate":"2010-05"},{"nctId":"NCT05476952","phase":"N/A","title":"The Effect of Lean Body Weight-adjusted Rocuronium Dose on Intubation Conditions: a Prospective Observational Study","status":"COMPLETED","sponsor":"DUYGU DEMİROZ","isPivotal":false,"enrollment":180,"indication":"Body Weight Changes, Rocuronium","completionDate":"2023-04-01"},{"nctId":"NCT03111810","phase":"Phase 2","title":"Targeting Iatrogenic Cushing's Syndrome With 11β-hydroxysteroid Dehydrogenase Type 1 Inhibition (TICSI)","status":"COMPLETED","sponsor":"University of Oxford","isPivotal":false,"enrollment":32,"indication":"Iatrogenic Cushing's Disease","completionDate":"2020-08-01"},{"nctId":"NCT00286780","phase":"Phase 2","title":"A Phase 2, Open Label Study of AT-101 in Combination With Rituximab in Patients With Relapse or Refractory Chronic Lymphocytic Leukemia","status":"COMPLETED","sponsor":"Ascenta Therapeutics","isPivotal":false,"enrollment":19,"indication":"Chronic Lymphocytic Leukemia","completionDate":"2007-11"},{"nctId":"NCT02689024","phase":"Phase 4","title":"A Multicenter Randomized Controlled Trial in Elderly Patients With Hip Fractures Comparing Continuous Fascia Iliaca Compartment Block to Systemic Opioids and Its Effect on Delirium Occurrence","status":"TERMINATED","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","isPivotal":false,"enrollment":239,"indication":"Hip Fractures, Anesthesia","completionDate":"2023-07-19"},{"nctId":"NCT06748313","phase":"NA","title":"Grand Challenges Fermented Food - Achars (fermented Pickles) in Pakistan","status":"COMPLETED","sponsor":"Aga Khan University","isPivotal":false,"enrollment":223,"indication":"Maternal Health, Gut Health","completionDate":"2022-10-10"},{"nctId":"NCT02472535","phase":"Phase 2","title":"A 12-week, Open-label, Dose-escalating, Phase 2 Study to Evaluate the Effects of MBX-8025 in Patients With Homozygous Familial Hypercholesterolemia (HoFH)","status":"COMPLETED","sponsor":"Gilead Sciences","isPivotal":false,"enrollment":13,"indication":"Homozygous Familial Hypercholesterolemia","completionDate":"2016-02"},{"nctId":"NCT01285635","phase":"Phase 2","title":"A Phase II of AT-101 in Combination With Docetaxel in Patients With Recurrent, Locally Advanced or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)","status":"TERMINATED","sponsor":"University of Michigan Rogel Cancer Center","isPivotal":false,"enrollment":35,"indication":"Squamous Cell Carcinoma of the Head and Neck (SCCHN)","completionDate":"2015-09"},{"nctId":"NCT06411938","phase":"NA","title":"A Community-based Cervical Cancer Prevention Program in Kenya: Overcoming Obstacles to Care, Promoting Understanding of HPV Natural History","status":"ACTIVE_NOT_RECRUITING","sponsor":"Indiana University","isPivotal":false,"enrollment":2300,"indication":"Cervical Cancer Prevention, Cervical Cancer","completionDate":"2026-05-01"},{"nctId":"NCT01568216","phase":"Phase 2","title":"\"A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Add-on AMG 747 on Schizophrenia Negative Symptoms\"","status":"TERMINATED","sponsor":"Amgen","isPivotal":false,"enrollment":121,"indication":"Schizophrenia","completionDate":"2013-06"},{"nctId":"NCT04502394","phase":"Phase 1","title":"An Open-Label, Multicenter, Phase 1b/2 Study of the Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With Relapsed/Refractory Diffuse Large B-cell Lymphoma or Relapsed/Refr","status":"UNKNOWN","sponsor":"Kartos Therapeutics, Inc.","isPivotal":false,"enrollment":84,"indication":"Diffuse Large B Cell Lymphoma, Chronic Lymphocytic Leukemia","completionDate":"2024-03"},{"nctId":"NCT00569972","phase":"Phase 2","title":"PD 0200390 Dose Ranging Trial: A Randomized, Double Blind, Parallel Group, Placebo Controlled, Multicenter Outpatient Trial Of PD 0200390 In Adults With Primary Insomnia","status":"COMPLETED","sponsor":"Pfizer","isPivotal":false,"enrollment":682,"indication":"Insomnia","completionDate":"2009-01"},{"nctId":"NCT00571675","phase":"Phase 2","title":"A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase 2 Study Comparing AT-101 in Combination With Docetaxel and Prednisone Versus Docetaxel and Prednisone in Men With Chemotherapy-Naïve ","status":"COMPLETED","sponsor":"Ascenta Therapeutics","isPivotal":false,"enrollment":220,"indication":"Hormone Refractory Prostate Cancer","completionDate":"2010-09"},{"nctId":"NCT00813527","phase":"Phase 2","title":"A Double-blind, Randomized Study to Evaluate the Efficacy and Safety of TAK-475 or Placebo When Coadministered With Fenofibrate in Subjects With Combined Hyperlipidemia","status":"COMPLETED","sponsor":"Takeda","isPivotal":false,"enrollment":213,"indication":"Hyperlipidemias","completionDate":"2007-01"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{"icon":"","route":"OTIC","frequency":"","formulation":""},"formularyStatus":[],"developmentCodes":[],"ownershipHistory":[],"therapeuticAreas":["Other"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"companyName":"CHARTWELL RX","companyId":"chartwell-rx","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"Acetic acid is a compound that has been studied in various clinical trials, including those focused on heart failure, cardiomyopathies, and body weight changes. It has been used in combination with other substances, such as zinc acetate and OC000459, in trials examining its effects on left ventricular function and body weight.","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1960-05-17T00:00:00.000Z","mah":"HIKMA","brand_name_local":"VOSOL","application_number":"NDA012179"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1961-06-23T00:00:00.000Z","mah":"SAPTALIS PHARMS","brand_name_local":"VOSOL HC","application_number":"NDA012770"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1966-12-14T00:00:00.000Z","mah":"BAYER PHARMS","brand_name_local":"NEO-CORT-DOME","application_number":"NDA050238"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1976-06-02T00:00:00.000Z","mah":"OTSUKA ICU MEDCL","brand_name_local":"ACETIC ACID 0.25% IN PLASTIC CONTAINER","application_number":"NDA017656"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1977-05-11T00:00:00.000Z","mah":"KV PHARM","brand_name_local":"ACETIC ACID","application_number":"ANDA085493"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1978-02-21T00:00:00.000Z","mah":"BAYER PHARMS","brand_name_local":"TRIDESILON","application_number":"NDA017914"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1979-08-06T00:00:00.000Z","mah":"B BRAUN","brand_name_local":"ACETIC ACID 0.25% IN PLASTIC CONTAINER","application_number":"NDA018161"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1979-10-26T00:00:00.000Z","mah":"WARNER CHILCOTT","brand_name_local":"ORLEX","application_number":"ANDA086845"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1980-03-03T00:00:00.000Z","mah":"WARNER CHILCOTT","brand_name_local":"ORLEX HC","application_number":"ANDA086844"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1981-08-12T00:00:00.000Z","mah":"ACTAVIS MID ATLANTIC","brand_name_local":"ACETASOL","application_number":"ANDA087146"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1982-01-13T00:00:00.000Z","mah":"ACTAVIS MID ATLANTIC","brand_name_local":"ACETASOL HC","application_number":"ANDA087143"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1982-02-19T00:00:00.000Z","mah":"BAXTER HLTHCARE","brand_name_local":"ACETIC ACID 0.25% IN PLASTIC CONTAINER","application_number":"NDA018523"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1984-09-06T00:00:00.000Z","mah":"SUN PHARMA CANADA","brand_name_local":"ACETIC ACID","application_number":"ANDA088638"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"1994-02-25T00:00:00.000Z","mah":"BAUSCH AND LOMB","brand_name_local":"ACETIC ACID 2% IN AQUEOUS ALUMINUM ACETATE","application_number":"ANDA040063"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2005-02-24T00:00:00.000Z","mah":"SCIEGEN PHARMS","brand_name_local":"ACETIC ACID","application_number":"ANDA040607"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2018-03-09T00:00:00.000Z","mah":"RISING","brand_name_local":"ACETIC ACID","application_number":"ANDA207280"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":"PHARMAFAIR","brand_name_local":"BOROFAIR","application_number":"ANDA088606"}],"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}